
Loading
Loading

Growth-Factor Research
A modified growth-hormone-releasing hormone analogue supplied as a 5 mg lyophilized vial for in-vitro and analytical research applications.
Certificate of Analysis
Canada-wide shipping
Tracked delivery
Lyophilized
Cold-chain handling
Certificate of Analysis
PeakTrace
99.72%
purity
Independent analytical laboratory. It certifies the measured purity of the vial analysed — not a full identity characterisation, and not proof that other units are identical.
View the CoAFor laboratory research use only. Not for human or veterinary use. No dosing or administration guidance is provided.
CJC-1295 is a synthetic analogue of the first 29 residues of growth-hormone-releasing hormone (GHRH). The “with DAC” form carries a Drug Affinity Complex, a reactive linker that binds covalently to serum albumin, and appears in research on GHRH-receptor signalling and on peptide half-life extension. Supplied for laboratory research only; no therapeutic, efficacy, or human/veterinary-use claims are made.
Provided for research context only. This material is supplied for laboratory, analytical, and research use exclusively — not for human or veterinary use. No therapeutic, diagnostic, dosing, or efficacy claims are made or implied.
A modified growth-hormone-releasing hormone analogue supplied as a 5 mg lyophilized vial for in-vitro and analytical research applications.
CJC-1295 with DAC 5 mg is listed within the growth-factor research category as a research reference material. This entry provides general and molecular reference information. Batch-specific documentation is published only when verified records are available for a listed material.
No reviews yet. Be the first to review CJC-1295 with DAC 5 mg.
Reviews are by invitation — we email a link once an order has been delivered.